XML 40 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Provision for Income Taxes Based on Losses from Continuing Operations

The provision for income taxes based on losses from continuing operations consists of the following at December 31:

 

 

Years ended December 31,

 

(in thousands)

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

State

 

$

 

 

$

 

Total current provision

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

Federal

 

 

(8,697

)

 

 

(8,300

)

State

 

 

(566

)

 

 

(789

)

Total deferred (benefit) expense

 

 

(9,263

)

 

 

(9,089

)

Valuation allowance

 

 

9,263

 

 

 

9,089

 

Total income tax provision

 

$

 

 

$

 

Schedule of Significant Components of the Company's Taxes and the Rates

Significant components of the Company’s taxes and the rates as of December 31 are shown below:

 

 

Years ended December 31,

 

(in thousands, except percentages)

 

2024

 

 

2023

 

Tax computed at the federal statutory rate

 

$

(9,540

)

 

 

21

%

 

$

(8,703

)

 

 

21

%

State tax, net of federal tax benefit

 

 

(517

)

 

 

1

%

 

 

(645

)

 

 

2

%

Permanent items

 

 

2

 

 

 

%

 

 

(2

)

 

 

%

Stock based compensation

 

 

1,070

 

 

 

(2

)%

 

 

902

 

 

 

(2

)%

Research and development credits

 

 

(642

)

 

 

1

%

 

 

(515

)

 

 

1

%

Other

 

 

364

 

 

 

(1

)%

 

 

(126

)

 

 

%

Valuation allowance increase (decrease)

 

 

9,263

 

 

 

(20

)%

 

 

9,089

 

 

 

(22

)%

Provision for income taxes

 

$

 

 

 

%

 

$

 

 

 

%

Schedule of Significant Components of the Company's Deferred Tax Assets

Significant components of the Company’s deferred tax assets and liabilities from federal and state income taxes as of December 31 are shown below (in thousands):

 

 

Years ended December 31,

 

(in thousands)

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Tax loss carryforwards

 

$

27,374

 

 

$

23,441

 

Research and development credits and other tax credits

 

 

4,556

 

 

 

3,611

 

Stock-based compensation

 

 

1,252

 

 

 

1,407

 

Capitalized research and development

 

 

14,209

 

 

 

9,687

 

Operating lease liabilities

 

 

327

 

 

 

471

 

Other

 

 

967

 

 

 

929

 

Total deferred tax assets

 

 

48,685

 

 

 

39,546

 

Deferred tax liabilities:

 

 

 

 

 

 

Operating lease right-of-use assets

 

 

(251

)

 

 

(375

)

Total deferred tax liabilities

 

 

(251

)

 

 

(375

)

Net deferred tax assets before valuation allowance

 

 

48,434

 

 

 

39,171

 

Valuation allowance

 

 

(48,434

)

 

 

(39,171

)

Net deferred tax asset

 

$

 

 

$